OM1 LAUNCHES NEW MENTAL HEALTH AND NEUROSCIENCE REAL-WORLD DATA NETWORK

Mar 31, 2022

Dr. Carl D. Marci joins OM1 to lead specialty area focused on major depression, schizophrenia, multiple sclerosis, and more

Posted by OM1

OM1 LAUNCHES NEW MENTAL HEALTH AND NEUROSCIENCE REAL-WORLD DATA NETWORK

Dr. Carl D. Marci joins OM1 to lead specialty area focused on major depression, schizophrenia, multiple sclerosis, and more

BOSTON, March 31, 2022 — OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, today announces the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric disorders and diseases of the central nervous system (CNS) with an initial focus on major depression, schizophrenia, bipolar disorder, and multiple sclerosis (MS) with other condition areas to follow. 

Mental health and CNS disorders are areas of unmet and growing medical need in the U.S. In particular, mental health disorders have been exacerbated by the pandemic and now constitute a national crisis. Despite increased early-stage investment in developing and testing new treatments for these conditions, high quality insights to drive research that enables market adoption and personalized care are lacking or have been difficult to attain.

Real-world data with clinical depth and nuance are critically needed to understand disease progression, patient characteristics, condition subtypes and variations — as well as the costs and clinical outcomes of new and existing treatments. Continue reading.

Download Attachment

See all Member News